SCHEMBL14950293

SCHEMBL14950293

COc1ccc(-c2cn(C(=O)N(C)C3CCOCC3)cn2)cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.46
CES2 O00748 1/20 0.46
NPC1 O15118 3/20 0.42
RAB9A P51151 2/20 0.42
GRM2 Q14416 1/20 0.37
GRIN1 Q05586 2/20 0.36
GRIN2B Q13224 2/20 0.36
GAK O14976 3/20 0.36
PRKDC P78527 1/20 0.36
PIK3CD O00329 1/20 0.36
PDE4B Q07343 2/20 0.35
TGFBR1 P36897 1/20 0.35
TTK P33981 1/20 0.35
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
KCNH2 Q12809 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35
APH1A Q96BI3 1/20 0.35
PSENEN Q9NZ42 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL428163 0.92 FAAH (0.48) FAAHCES2NPC1RAB9AGAK
SCHEMBL427345 0.89 FAAH (0.46) FAAHCES2NPC1RAB9AGRIN1
SCHEMBL428157 0.89 FAAH (0.46) FAAHCES2NPC1RAB9APIK3CD
SCHEMBL16424116 0.88 FAAH (0.46) FAAHCES2GRIN1GRIN2BGAK
Hydrochloric Acid SCHEMBL16416787 0.87 FAAH (0.46) FAAHCES2GRIN1GRIN2BGAK
SCHEMBL427411 0.87 FAAH (0.48) FAAHCES2NPC1RAB9APIK3CD
SCHEMBL14937556 0.87 FAAH (0.46) FAAHCES2NPC1RAB9APIK3CD
SCHEMBL14937905 0.87 TBK1 (0.45) FAAHCES2NPC1RAB9A
SCHEMBL426156 0.86 FAAH (0.50) FAAHCES2NPC1RAB9AGRIN1
SCHEMBL17838084 0.86 FAAH (0.45) FAAHCES2GRIN1GRIN2BPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130123493-A1 PROCESS FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS BIAL - PORTELA & CA, S.A. (PT) 2013-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130123493-A1 PROCESS FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS UTS2R, ARG1, PRMT1 FAAH 2166/4885CES2 463/4885NPC1 2780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.